Entry - #614067 - SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52 - OMIM
# 614067

SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52


Alternative titles; symbols

CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 6, FORMERLY; CPSQ6, FORMERLY


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q12 Spastic paraplegia 52, autosomal recessive 614067 AR 3 AP4S1 607243
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Height
- Short stature
HEAD & NECK
Head
- Microcephaly
Face
- Coarse facial features
- Short philtrum
- Facial hypotonia
Eyes
- Hypertelorism
Nose
- Broad nasal bridge
- Prominent nose
- Bulbous nose
Mouth
- Wide mouth
- Full lips
- High-arched palate
SKELETAL
- Joint contractures
Feet
- Talipes equinovarus
MUSCLE, SOFT TISSUES
- Hypertonia
- Axial hypotonia
- Decreased shank muscle mass
NEUROLOGIC
Central Nervous System
- Delayed psychomotor development
- Mental retardation, severe
- Spasticity
- Hyperreflexia
- Loss of ability to walk
- Extensor plantar responses
- Lack of speech development
- Febrile seizures (in some patients)
- Focal seizures (in some patients)
- Thin or absent corpus callosum (in some patients)
Behavioral Psychiatric Manifestations
- Stereotypic laughter
- Shy character
- Amicable character
MISCELLANEOUS
- Onset at birth
- Two unrelated families have been reported (last curated May 2016)
MOLECULAR BASIS
- Caused by mutation in the adaptor-related protein complex 4, sigma-1 subunit (AP4S1, 607243.0001)
Spastic paraplegia - PS303350 - 86 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.13 Spastic paraplegia 78, autosomal recessive AR 3 617225 ATP13A2 610513
1p34.1 Spastic paraplegia 83, autosomal recessive AR 3 619027 HPDL 618994
1p31.1-p21.1 Spastic paraplegia 29, autosomal dominant AD 2 609727 SPG29 609727
1p13.3 ?Spastic paraplegia 63, autosomal recessive AR 3 615686 AMPD2 102771
1p13.2 Spastic paraplegia 47, autosomal recessive AR 3 614066 AP4B1 607245
1q32.1 Spastic paraplegia 23, autosomal recessive AR 3 270750 DSTYK 612666
1q42.13 ?Spastic paraplegia 44, autosomal recessive AR 3 613206 GJC2 608803
1q42.13 ?Spastic paraplegia 74, autosomal recessive AR 3 616451 IBA57 615316
2p23.3 Spastic paraplegia 81, autosomal recessive AR 3 618768 SELENOI 607915
2p22.3 Spastic paraplegia 4, autosomal dominant AD 3 182601 SPAST 604277
2p13.3 Spastic paraplegia 93, autosomal recessive AR 3 620938 NFU1 608100
2p11.2 Spastic paraplegia 31, autosomal dominant AD 3 610250 REEP1 609139
2q33.1 Spastic paraplegia 13, autosomal dominant AD 3 605280 HSPD1 118190
2q37.3 Spastic paraplegia 30, autosomal dominant AD 3 610357 KIF1A 601255
2q37.3 Spastic paraplegia 30, autosomal recessive AR 3 620607 KIF1A 601255
3q12.2 ?Spastic paraplegia 57, autosomal recessive AR 3 615658 TFG 602498
3q25.31 Spastic paraplegia 42, autosomal dominant AD 3 612539 SLC33A1 603690
3q27-q28 Spastic paraplegia 14, autosomal recessive AR 2 605229 SPG14 605229
4p16-p15 Spastic paraplegia 38, autosomal dominant AD 2 612335 SPG38 612335
4p13 Spastic paraplegia 79A, autosomal dominant AD 3 620221 UCHL1 191342
4p13 Spastic paraplegia 79B, autosomal recessive AR 3 615491 UCHL1 191342
4q25 Spastic paraplegia 56, autosomal recessive AR 3 615030 CYP2U1 610670
5q31.2 Spastic paraplegia 72A, autosomal dominant AD 3 615625 REEP2 609347
5q31.2 ?Spastic paraplegia 72B, autosomal recessive AR 3 620606 REEP2 609347
6p25.1 Spastic paraplegia 77, autosomal recessive AR 3 617046 FARS2 611592
6p21.33 Spastic paraplegia 86, autosomal recessive AR 3 619735 ABHD16A 142620
6q23-q24.1 Spastic paraplegia 25, autosomal recessive AR 2 608220 SPG25 608220
7p22.1 Spastic paraplegia 48, autosomal recessive AR 3 613647 AP5Z1 613653
7q22.1 Spastic paraplegia 50, autosomal recessive AR 3 612936 AP4M1 602296
8p22 Spastic paraplegia 53, autosomal recessive AR 3 614898 VPS37A 609927
8p21.1-q13.3 Spastic paraplegia 37, autosomal dominant AD 2 611945 SPG37 611945
8p11.23 Spastic paraplegia 18B, autosomal recessive AR 3 611225 ERLIN2 611605
8p11.23 Spastic paraplegia 18A, autosomal dominant AD 3 620512 ERLIN2 611605
8p11.23 Spastic paraplegia 54, autosomal recessive AR 3 615033 DDHD2 615003
8p11.21 Spastic paraplegia 85, autosomal recessive AR 3 619686 RNF170 614649
8q12.3 Spastic paraplegia 5A, autosomal recessive AR 3 270800 CYP7B1 603711
8q24.13 Spastic paraplegia 8, autosomal dominant AD 3 603563 WASHC5 610657
9p13.3 Spastic paraplegia 46, autosomal recessive AR 3 614409 GBA2 609471
9q Spastic paraplegia 19, autosomal dominant AD 2 607152 SPG19 607152
9q34.11 Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia AD 3 620538 SPTAN1 182810
10q22.1-q24.1 Spastic paraplegia 27, autosomal recessive AR 2 609041 SPG27 609041
10q24.1 Spastic paraplegia 9A, autosomal dominant AD 3 601162 ALDH18A1 138250
10q24.1 Spastic paraplegia 9B, autosomal recessive AR 3 616586 ALDH18A1 138250
10q24.1 Spastic paraplegia 64, autosomal recessive AR 3 615683 ENTPD1 601752
10q24.31 Spastic paraplegia 62, autosomal recessive AR 3 615681 ERLIN1 611604
10q24.32-q24.33 Spastic paraplegia 45, autosomal recessive AR 3 613162 NT5C2 600417
11p14.1-p11.2 ?Spastic paraplegia 41, autosomal dominant AD 2 613364 SPG41 613364
11q12.3 Silver spastic paraplegia syndrome AD 3 270685 BSCL2 606158
11q13.1 Spastic paraplegia 76, autosomal recessive AR 3 616907 CAPN1 114220
12q13.3 Spastic paraplegia 70, autosomal recessive AR 3 620323 MARS1 156560
12q13.3 Spastic paraplegia 10, autosomal dominant AD 3 604187 KIF5A 602821
12q13.3 Spastic paraplegia 26, autosomal recessive AR 3 609195 B4GALNT1 601873
12q23-q24 Spastic paraplegia 36, autosomal dominant AD 2 613096 SPG36 613096
12q23.3 Spastic paraplegia 92, autosomal recessive AR 3 620911 FICD 620875
12q24.31 Spastic paraplegia 55, autosomal recessive AR 3 615035 MTRFR 613541
13q13.3 Troyer syndrome AR 3 275900 SPART 607111
13q14 Spastic paraplegia 24, autosomal recessive AR 2 607584 SPG24 607584
13q14.2 Spastic paraplegia 88, autosomal dominant AD 3 620106 KPNA3 601892
14q12-q21 Spastic paraplegia 32, autosomal recessive AR 2 611252 SPG32 611252
14q12 Spastic paraplegia 52, autosomal recessive AR 3 614067 AP4S1 607243
14q13.1 Spastic paraplegia 90A, autosomal dominant AD 3 620416 SPTSSA 613540
14q13.1 ?Spastic paraplegia 90B, autosomal recessive AD 3 620417 SPTSSA 613540
14q22.1 Spastic paraplegia 3A, autosomal dominant AD 3 182600 ATL1 606439
14q22.1 Spastic paraplegia 28, autosomal recessive AR 3 609340 DDHD1 614603
14q24.1 Spastic paraplegia 15, autosomal recessive AR 3 270700 ZFYVE26 612012
14q24.3 Spastic paraplegia 87, autosomal recessive AR 3 619966 TMEM63C 619953
15q11.2 Spastic paraplegia 6, autosomal dominant AD 3 600363 NIPA1 608145
15q21.1 Spastic paraplegia 11, autosomal recessive AR 3 604360 SPG11 610844
15q21.2 Spastic paraplegia 51, autosomal recessive AR 3 613744 AP4E1 607244
15q22.31 Mast syndrome AR 3 248900 ACP33 608181
16p12.3 Spastic paraplegia 61, autosomal recessive AR 3 615685 ARL6IP1 607669
16q13 Spastic paraplegia 89, autosomal recessive AR 3 620379 AMFR 603243
16q23.1 Spastic paraplegia 35, autosomal recessive AR 3 612319 FA2H 611026
16q24.3 Spastic paraplegia 7, autosomal recessive AD, AR 3 607259 PGN 602783
17q25.3 Spastic paraplegia 82, autosomal recessive AR 3 618770 PCYT2 602679
19p13.2 Spastic paraplegia 39, autosomal recessive AR 3 612020 PNPLA6 603197
19q12 ?Spastic paraplegia 43, autosomal recessive AR 3 615043 C19orf12 614297
19q13.12 Spastic paraplegia 75, autosomal recessive AR 3 616680 MAG 159460
19q13.32 Spastic paraplegia 12, autosomal dominant AD 3 604805 RTN2 603183
19q13.33 ?Spastic paraplegia 73, autosomal dominant AD 3 616282 CPT1C 608846
22q11.21 Spastic paraplegia 84, autosomal recessive AR 3 619621 PI4KA 600286
Xq11.2 Spastic paraplegia 16, X-linked, complicated XLR 2 300266 SPG16 300266
Xq22.2 Spastic paraplegia 2, X-linked XLR 3 312920 PLP1 300401
Xq24-q25 Spastic paraplegia 34, X-linked XLR 2 300750 SPG34 300750
Xq28 MASA syndrome XLR 3 303350 L1CAM 308840
Not Mapped Spastic paraplegia 33, autosomal dominant AD 610244 SPG33 610244

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive spastic paraplegia-52 (SPG52) is caused by homozygous or compound heterozygous mutation in the AP4S1 gene (607243) on chromosome 14q12.


Description

Spastic quadriplegia-52 (SPG52) is an autosomal recessive neurodevelopmental disorder characterized by neonatal hypotonia that progresses to hypertonia and spasticity and severe mental retardation with poor or absent speech development (summary by Abou Jamra et al., 2011). Some patients may have seizures (Hardies et al., 2015).

For a discussion of genetic heterogeneity of autosomal recessive spastic paraplegia, see SPG5A (270800).


Clinical Features

Abou Jamra et al. (2011) reported a consanguineous Syrian kindred (MR061) in which 5 individuals had severe mental retardation and spasticity. They had delayed motor development in infancy, but lost the ability to walk in early childhood due to spasticity. Physical examination showed muscular hypertonia, especially of lower limbs, contractures, talipes equinovarus, decreased shank muscle mass, short stature, and microcephaly. All had a severe cognitive deficit and absent speech and could only express basic needs. Dysmorphic features included a prominent and bulbous nose, wide mouth, and coarse features. All were markedly shy, amicable, and calm, and kept smiling or laughing for no obvious reason, but did not have laughter bursts. None of the patients had seizures, a hearing impairment, or any anomalies of inner organs.

Hardies et al. (2015) reported 2 sisters, born of unrelated Caucasian parents, with developmental delay, febrile seizures, and spastic paraplegia. The patients were 14 and 13 years old at the time of the report. The older sister had 5 brief generalized febrile seizures between 5 months and 5 years of age, and seizure onset was associated with a stagnation in development. The seizures were well controlled and then remitted without treatment between 10 and 13 years. They subsequently recurred as afebrile focal tonic and tonic-clonic seizures with partial response to treatment. Her sister had apneic episodes until the age of 3 months and then showed delayed psychomotor development. She had 2 simple febrile seizures at the age of 1 and 2 years, followed by partially controlled afebrile focal seizures after age 9 years. Both girls had profound intellectual disability, axial hypotonia, and spastic diplegia; one had microcephaly (-3 SD). Brain MRI of the older sister showed dilation of the lateral ventricles and hypoplasia of the posterior portion of the corpus callosum. Brain MRI of the younger sister showed nonprogressive hydrocephalus due to congenital stenosis of the aqueduct of Sylvius with severe reduction of subcortical white matter, absence of the corpus callosum, and a lack of white-gray matter differentiation in basal ganglia. Both girls also had facial hypotonia and dysmorphic features, including broad nasal bridge, hypertelorism, arched eyebrows, bulbous nose, short philtrum, wide mouth with full lips, and high palate.


Inheritance

The transmission pattern of SPG52 in the family reported by Hardies et al. (2015) was consistent with autosomal recessive inheritance.


Molecular Genetics

By linkage analysis followed by candidate gene sequencing of a Syrian family with autosomal recessive mental retardation and spasticity, Abou Jamra et al. (2011) identified a homozygous truncating mutation in the AP4S1 gene (607243.0001). The authors concluded that AP4-complex-mediated vesicular trafficking plays a crucial role in brain development and function.

In 2 sisters, born of unrelated Caucasian parents, with SPG52 and seizures, Hardies et al. (2015) identified compound heterozygous truncating mutations in the AP4S1 gene (607243.0002 and 607243.0003). The mutations, which were found by whole-genome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Western blot analysis of cells derived from 1 sister showed absence of the AP4S1 protein and a substantial reduction in all other AP4 subunits compared to controls. Immunoprecipitation studies confirmed the reduction of AP4 subunits and also showed impaired assembly of the complex. The findings implicated a defect in endosomal trafficking in both epilepsy and spastic paraplegia.


REFERENCES

  1. Abou Jamra, R., Philippe, O., Raas-Rothschild, A., Eck, S. H., Graf, E., Buchert, R., Borck, G., Ekici, A., Brockschmidt, F. F., Nothen, M. M., Munnich, A., Strom, T. M., Reis, A., Colleaux, L. Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am. J. Hum. Genet. 88: 788-795, 2011. [PubMed: 21620353, images, related citations] [Full Text]

  2. Hardies, K., May, P., Djemie, T., Tarta-Arsene, O., Deconinck, T., Craiu, D., AR Working Group of the EuroEPINOMICS RES Consortium, Helbig, I., Suls, A., Balling, R., Weckhuysen, S., De Jonghe, P., Hirst, J. Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly. Hum. Molec. Genet. 24: 2218-2227, 2015. [PubMed: 25552650, images, related citations] [Full Text]


Contributors:
Cassandra L. Kniffin - updated : 5/19/2016
Creation Date:
Cassandra L. Kniffin : 6/29/2011
carol : 11/23/2021
alopez : 05/25/2016
ckniffin : 5/19/2016
carol : 4/24/2012
carol : 4/24/2012
ckniffin : 4/24/2012
wwang : 7/7/2011
wwang : 7/5/2011
ckniffin : 6/29/2011

# 614067

SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52


Alternative titles; symbols

CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 6, FORMERLY; CPSQ6, FORMERLY


ORPHA: 280763;   DO: 0110804;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q12 Spastic paraplegia 52, autosomal recessive 614067 Autosomal recessive 3 AP4S1 607243

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive spastic paraplegia-52 (SPG52) is caused by homozygous or compound heterozygous mutation in the AP4S1 gene (607243) on chromosome 14q12.


Description

Spastic quadriplegia-52 (SPG52) is an autosomal recessive neurodevelopmental disorder characterized by neonatal hypotonia that progresses to hypertonia and spasticity and severe mental retardation with poor or absent speech development (summary by Abou Jamra et al., 2011). Some patients may have seizures (Hardies et al., 2015).

For a discussion of genetic heterogeneity of autosomal recessive spastic paraplegia, see SPG5A (270800).


Clinical Features

Abou Jamra et al. (2011) reported a consanguineous Syrian kindred (MR061) in which 5 individuals had severe mental retardation and spasticity. They had delayed motor development in infancy, but lost the ability to walk in early childhood due to spasticity. Physical examination showed muscular hypertonia, especially of lower limbs, contractures, talipes equinovarus, decreased shank muscle mass, short stature, and microcephaly. All had a severe cognitive deficit and absent speech and could only express basic needs. Dysmorphic features included a prominent and bulbous nose, wide mouth, and coarse features. All were markedly shy, amicable, and calm, and kept smiling or laughing for no obvious reason, but did not have laughter bursts. None of the patients had seizures, a hearing impairment, or any anomalies of inner organs.

Hardies et al. (2015) reported 2 sisters, born of unrelated Caucasian parents, with developmental delay, febrile seizures, and spastic paraplegia. The patients were 14 and 13 years old at the time of the report. The older sister had 5 brief generalized febrile seizures between 5 months and 5 years of age, and seizure onset was associated with a stagnation in development. The seizures were well controlled and then remitted without treatment between 10 and 13 years. They subsequently recurred as afebrile focal tonic and tonic-clonic seizures with partial response to treatment. Her sister had apneic episodes until the age of 3 months and then showed delayed psychomotor development. She had 2 simple febrile seizures at the age of 1 and 2 years, followed by partially controlled afebrile focal seizures after age 9 years. Both girls had profound intellectual disability, axial hypotonia, and spastic diplegia; one had microcephaly (-3 SD). Brain MRI of the older sister showed dilation of the lateral ventricles and hypoplasia of the posterior portion of the corpus callosum. Brain MRI of the younger sister showed nonprogressive hydrocephalus due to congenital stenosis of the aqueduct of Sylvius with severe reduction of subcortical white matter, absence of the corpus callosum, and a lack of white-gray matter differentiation in basal ganglia. Both girls also had facial hypotonia and dysmorphic features, including broad nasal bridge, hypertelorism, arched eyebrows, bulbous nose, short philtrum, wide mouth with full lips, and high palate.


Inheritance

The transmission pattern of SPG52 in the family reported by Hardies et al. (2015) was consistent with autosomal recessive inheritance.


Molecular Genetics

By linkage analysis followed by candidate gene sequencing of a Syrian family with autosomal recessive mental retardation and spasticity, Abou Jamra et al. (2011) identified a homozygous truncating mutation in the AP4S1 gene (607243.0001). The authors concluded that AP4-complex-mediated vesicular trafficking plays a crucial role in brain development and function.

In 2 sisters, born of unrelated Caucasian parents, with SPG52 and seizures, Hardies et al. (2015) identified compound heterozygous truncating mutations in the AP4S1 gene (607243.0002 and 607243.0003). The mutations, which were found by whole-genome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Western blot analysis of cells derived from 1 sister showed absence of the AP4S1 protein and a substantial reduction in all other AP4 subunits compared to controls. Immunoprecipitation studies confirmed the reduction of AP4 subunits and also showed impaired assembly of the complex. The findings implicated a defect in endosomal trafficking in both epilepsy and spastic paraplegia.


REFERENCES

  1. Abou Jamra, R., Philippe, O., Raas-Rothschild, A., Eck, S. H., Graf, E., Buchert, R., Borck, G., Ekici, A., Brockschmidt, F. F., Nothen, M. M., Munnich, A., Strom, T. M., Reis, A., Colleaux, L. Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am. J. Hum. Genet. 88: 788-795, 2011. [PubMed: 21620353] [Full Text: https://doi.org/10.1016/j.ajhg.2011.04.019]

  2. Hardies, K., May, P., Djemie, T., Tarta-Arsene, O., Deconinck, T., Craiu, D., AR Working Group of the EuroEPINOMICS RES Consortium, Helbig, I., Suls, A., Balling, R., Weckhuysen, S., De Jonghe, P., Hirst, J. Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly. Hum. Molec. Genet. 24: 2218-2227, 2015. [PubMed: 25552650] [Full Text: https://doi.org/10.1093/hmg/ddu740]


Contributors:
Cassandra L. Kniffin - updated : 5/19/2016

Creation Date:
Cassandra L. Kniffin : 6/29/2011

Edit History:
carol : 11/23/2021
alopez : 05/25/2016
ckniffin : 5/19/2016
carol : 4/24/2012
carol : 4/24/2012
ckniffin : 4/24/2012
wwang : 7/7/2011
wwang : 7/5/2011
ckniffin : 6/29/2011